Testimonials
Click on the text to pause the slider.
Resources
A NEW WAY TO PLAN YOUR LUNG CANCER PROGRAM
Healthcare professionals, financial experts, and administrators can generate predictive reports customized for their lung cancer screening and nodule management programs after downloading the interactive model and entering data. Key initial questions gather data about your facility type, patient volume and growth rates, cancer incidence rates, the impact of patient navigators, and infrastructure costs.
A NEW GENERATION OF LUNG PROGRAM MODELING
This new generation modeling tool will help you to build a new lung cancer screening and nodule management program or to expand your existing program. After you enter some initial information about your facility type and patient volumes, the model will create a 5-year projection of the modeled early-detection program.
SUPPORT RESOURCES FOR A FAST START
LungPLAN is part of a new generation of lung program forecasting tools, and it comes with supportive training resources including materials for sharing with your team, a user manual to explain operational details, and step-by-step training videos that make it easy for you to follow along. You can talk to a support person if you have additional questions.
LAUNCH WEBINAR – INTRODUCTION TO LungPLAN
This April 13, 2022, launch webinar gave a short tutorial on how LungPLAN can be used by clinicians and lung cancer professionals to model the business cases for their lung cancer screening and nodule management programs. The motivations and principles of the LungPLAN project were described by members of the NLCRT LungPLAN team, and the main features and capabilities of the tool were demonstrated by the developer. The webinar concluded with a short Q&A session.
LungPLAN FINANCIAL MODELING AND FORECASTING TOOL
This 2021 NLCRT Annual Meeting LungPLAN presentation gives you an executive summary of how to use LungPLAN to predict the financial performance of new or existing lung cancer early detection programs over a 5-year period.
Acknowledgments
The American Cancer Society National Lung Cancer Roundtable (NLCRT) was established in 2017 and is a consortium of more than 210 member organizations and 225 leading experts working together to create lung cancer survivors and improve the quality of life for those at risk for lung cancer and lung cancer patients and their families. We engage volunteer experts, including patient and caregiver advocate representatives, in multidisciplinary collaborations that drive the national conversation, catalyze action to create, build, and strengthen innovative solutions, and develop and disseminate evidence-based interventions and best practices. Our collective power and expertise propel us to take on challenges that reduce the impact of lung cancer through risk reduction, tobacco prevention, and control, early detection, improved lung cancer imaging, assurance of optimal diagnosis to position patients for appropriate therapy and care, eliminating lung cancer-related stigma, and strengthening state-based initiatives. By working together and avoiding duplication, we will drive progress faster than working alone to overcome lung cancer challenges, accelerate change, and address the determinants of cancer-related health disparities to advance health equity across the lung cancer continuum. This is the unique role of the NLCRT. The NLCRT is thankful for the financial support from its partners and the American Cancer Society that propel this work forward. We especially wish to thank the NLCRT Lung Cancer Early Detection Implementation Strategies Task Group, The FiscalHealth Group, and Ohlander Consulting Services, Inc. for their expertise and the many hours of review and deliberation that went into developing LungPLAN™. For a full list of acknowledgments, click here.